3:22-CV-03610
06/08/2022
Pending - Other Pending
Intellectual Property - Patent
EISAI CO., LTD.
EISAI INC.
NOVARTIS PHARMA AG
AUROBINDO PHARMA LTD.
AUROBINDO PHARMA USA, INC.
WILLIAM P. DENI, JR.
Attorney at GIBBONS, PC
One Gateway Center
Newark, NJ 07102-5310
Main Document
Exhibit A
Civil Cover Sheet
L. Civ. R. 11.2 & 40.1 Certification
(#2) Corporate Disclosure Statement by EISAI CO., LTD., EISAI INC.. (DENI, WILLIAM) (Entered: 06/08/2022)
(#3) Corporate Disclosure Statement by NOVARTIS PHARMA AG. (DENI, WILLIAM) (Entered: 06/08/2022)
Docket(#3) Corporate Disclosure Statement by NOVARTIS PHARMA AG. (DENI, WILLIAM) (Entered: 06/08/2022)
Docket(#2) Corporate Disclosure Statement by EISAI CO., LTD., EISAI INC.. (DENI, WILLIAM) (Entered: 06/08/2022)
Docket(#1) COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13472715) , Related Case Selected, filed by EISAI CO., LTD., NOVARTIS PHARMA AG, EISAI INC.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet, #3 L. Civ. R. 11.2 & 40.1 Certification)(DENI, WILLIAM) (Entered: 06/08/2022)
Dig Deeper
Get Deeper Insights on Court Cases